The clinical efficacy of continuous-infusion flucloxacillin in serious staphylococcal sepsis

Journal of Antimicrobial Chemotherapy

Volumn 43, Issue 1, 1999, Pages 113-118

  Leder, Karin ^a   Turnidge, John D ^b   Korman, Tony M ^a   Grayson, M Lindsay ^a,c  

^a MONASH MEDICAL CENTRE   (Australia)

^b WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; FLUCLOXACILLIN;

ABSCESS; ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL ENDOCARDITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; FOLLOW UP; HOME CARE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MINIMUM INHIBITORY CONCENTRATION; OSTEOMYELITIS; RASH; SEPSIS; STAPHYLOCOCCUS INFECTION;

ADOLESCENT; ADULT; AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLOXACILLIN; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PENICILLINS; SEPSIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

EID: 0032926416     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/43.1.113     Document Type: Article

References (31)

1. Patel, K. B., Nicolau, D. P., Nightingale, C. H. & Quintiliani, R. (1995). Continuous-infusion β-lactam antibiotics: a rational dosing approach. Connecticut Medicine 59, 471-3.
2. Visser, L. G., Arnouts, P., van Furth, R., Mattie, H. & van den Broek, P. J. (1993). Clinical pharmacokinetics of continuous intravenous administration of penicillins. Clinical Infectious Diseases 17, 491-5.
3. Turnidge, J. D. (1998). The pharmacodynamics of β-lactams. Clinical Infectious Diseases 27, 10-22.
4. Craig, W. A. & Ebert, S. C. (1992). Continuous-infusion of β-lactam antibiotics. Antimicrobial Agents and Chemotherapy 36, 2577-83.
5. Scheld, W. M. & Sande, M. A. (1995). Endocarditis and intravascular infections. In Principles and Practice of Infectious Diseases, 4th edn, (Mandell, G. L., Bennett, J. E. & Dolin, R., Eds), pp. 740-83. Churchill Livingstone, Edinburgh.
6. Kloos, W. E. & Bannerman, T. L. (1995). Staphylococcus and Micrococcus. In Manual of Clinical Microbiology, 6th edn, (Murray. P. R., Baron, E. J., Pfaller, M. A., Tenover, F. C. & Yolken, R. H., Eds), pp. 282-98. ASM Press, Washington, DC.
7. National Committee for Clinical Laboratory Standards. (1993). Performance Standards for Antimicrobial Disk Susceptibilty Tests -Sixth Edition: Document M2-A6. NCCLS, Villanova, PA.
8. Trissel, L. A. (1996). Flucloxacillin sodium. In Handbook on Injectable Drugs, 9th edn, pp. 1134-8. American Society of Health-System Pharmacists, Bethesda, MD.
9. Edberg, S. C. (1986). The measurement of antibiotics in human body fluids: techniques and significance. In Antibiotics in Laboratory Medicine, 2nd edn, (Lorian, V., Ed), pp. 381-514. Williams and Wilkins, Baltimore, MD.
10. Fairley, C. K., McNeil, J. J., Desmond, P., Smallwood, R., Young, H., Forbes, A. et al. (1993). Risk factors for development of flucloxacillin associated jaundice. British Medical Journal 306, 233-5.
11. Olsson, R., Wiholm, B. E., Sand, C., Zettergren, L., Hultcrantz, R. & Myrhed, M. (1992). Liver damage from flucloxacillin, cloxacillin and dicloxacillin. Journal of Hepatology 15, 154-61.
12. Thauvin, C., Eliopoulos, G. M., Willey, S., Wennersten, C. & Moellering, R. C. (1987). Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats. Antimicrobial Agents and Chemotherapy 31, 139-43.
13. Raber, S., Leggett, J., Kohlhepp, S., Dworkin, R. & Gilbert, D. (1996). Continuous versus intermittent infusion of oxacillin in patients with staphylococcal infections. In Program and Abstracts of the Thirty-Sixth Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, 1996. Abstract A104, p. 20. American Society for Microbiology, Washington, DC.
14. Vondracek, T. G. (1995). β-Lactam antibiotics: is continuous infusion the preferred method of administration? Annals of Pharmacotherapy 29, 415-24.
15. Craig, W. A. (1994). Antibiotic selection factors and description of a hospital-based outpatient antibiotic therapy program in the USA. European Journal of Clinical Microbiology and Infectious Diseases 14, 636-42.
16. LeBel, M. & Spino, M. (1998). Pulse dosing versus continuous infusion of antibiotics. Clinical Pharmacokinetics 14, 71-95.
17. Daenen, S. & de Vries-Hospers, H. (1988). Cure of Pseudomonas aeruginosa infection in neutropenic patients by continuous infusion of ceftazidime. Lancet i, 937.
18. David, T. J. & Devlin, J. (1989). Continuous infusion of ceftazidime in cystic fibrosis. Lancet i, 1454-5.
19. Kuzemko, J. & Crawford, C. (1989). Continuous infusion of ceftazidime in cystic fibrosis. Lancet ii, 385.
20. Mylotte, J., Aeschlimann, J. R. & Rotella, D. L. (1996). Staphylococcus aureus bacteremia: factors predicting hospital mortality. Infection Control and Hospital Epidemiology 17, 165-8.
21. Mansur, A. J., Grinberg, M., Cardoso, A., Da Luz, P. L., Bellotti, G. & Pileggi, F. (1996). Determinants of prognosis in 300 episodes of infective endocarditis. Thoracic and Cardiovascular Surgeon 44, 2-10.
22. Mylotte, M. M., McDermott, C. & Spooner, J. A. (1987). Prospective study of 114 consecutive episodes of Staphylococcus aureus bacteremia. Reviews of Infectious Diseases 9, 891-907.
23. Benn, M., Hagelskjaer, L. H. & Tvede, M. (1997). Infective endocarditis, 1984 through 1993: a clinical and microbiological survey. Journal of Internal Medicine 242, 15-22.
24. Lynn, B. (1971). Recent work on parenteral penicillins. Journal of Hospital Pharmacy 29, 183-94.
25. Craig, W. A. & Ebert, S. C. (1989). Protein binding and its significance in antibacterial therapy. Infectious Disease Clinics of North America 3, 407-14.
26. Leggett, J. E., Wolz, S. A. & Craig, W. A. (1989). Use of serum ultrafiltrate in the serum dilution test. Journal of Infectious Diseases 160, 616-23.
27. Graham, D. R., Kelderman, M. M., Klemm, L. W., Semenza, N. J. & Shafer, M. L. (1991). Infectious complications among patients receiving home intravenous therapy with peripheral, central, or peripherally placed central venous catheters. American Journal of Medicine 91, 958-100S.
28. Wood, C. A. & Wisniewski, R. M. (1994). β-Lactam versus glycopeptides in treatment of subcutaneous abscesses infected with Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 38, 1023-6.
29. Graninger, W., Wenisch, C. & Hasenhundl, M. (1995). Treatment of staphylococcal infections. Current Opinion in Infectious Diseases 8, S20-8.
30. Mortara, L. A. & Bayer, A. S. (1993). Staphylococcus aureus bacteremia and endocarditis. Infectious Disease Clinics of North America 7, 53-68.
31. Grayson, M. L., Silvers, J. & Turnidge, J. (1995). Home intravenous antibiotic therapy: a safe and effective alternative to inpatient care. Medical Journal of Australia 162, 249-53.